Levetiracetam Accord

Levetiracetam, the active ingredient in Levetiracetam Accord, is an anticonvulsant presented as an oral formulation for oral use. It treats partial, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy. GNH USA supplies Levetiracetam Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an anticonvulsant used to manage seizure disorders across several epilepsy syndromes. - Partial seizures: reduces seizure frequency in patients with focal onset seizures. - Generalized tonic‑clonic seizures: helps control convulsive episodes in generalized epilepsy. - Myoclonic seizures: diminishes rapid, involuntary muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, most of which are mild to moderate.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired or low in energy. - Somnolence: increased sleepiness during the day. - Irritability or mood changes: mild emotional fluctuations.

Serious or Rare Side Effects: - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Suicidal thoughts or behavior: new or worsening depression or suicidal ideation. - Blood dyscrasias: rare cases of agranulocytosis or thrombocytopenia.

Levetiracetam requires careful consideration in certain clinical situations. - Renal impairment: dose may need adjustment based on creatinine clearance. - History of psychiatric disorders: monitor for mood changes or suicidal ideation. - Elderly patients: start at lower doses and titrate slowly. - Concomitant antiepileptic therapy: assess for additive CNS effects. - Store at room temperature below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Levetiracetam has a low potential for drug‑drug interactions, but some combinations require attention.

Major Interactions (Avoid): - Strong enzyme inducers (e.g., carbamazepine, phenytoin, phenobarbital): may markedly reduce levetiracetam plasma levels. - Alcohol: can enhance central nervous system depression.

Moderate Interactions (Monitor Closely): - Oral contraceptives: efficacy may be decreased, requiring additional contraceptive measures. - Sedative agents (e.g., benzodiazepines, opioids): may increase sedation. - Drugs cleared renally: monitor renal function and adjust dosing as needed.